Related Experiment Video
Updated: Jun 21, 2026
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients
Ali Osman Kaya1, Ugur Coskun, Banu Sancak
1Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey. aosmankaya@gmail.com
Purpose:
To evaluate the serum levels of G-CSF in patients with hepatocellular carcinoma and to compare with values in healthy individuals.
Patients And Methods:
Thirty-three patients with hepatocellular carcinoma and 30 controls were included in the study. Histological confirmation of hepatocellular carcinoma (HCC) was performed by core needle biopsy and patients with cirrhosis were classified according to the Child-Pugh score. The serum G-CSF levels of individuals in both groups were calculated as pg/ml and compared for Child-Pugh Class A, B and C patients with HCC.
Results:
Median ages of patients with HCC and control group individuals were 58 (range:47-78) and 56 (range 45-70), respectively. Sex distributions were approximately equal. The mean serum level of G-CSF in patients with HCC was 199.4-/+112.2, as compared to 24.0-/+8.8 in the controls (p <0.001). In addition, on subgroup analysis, the serum levels of G-CSF were increased with Child-Pugh Class A, B and C, although without statistical significance (p= 0.253).
Conclusion:
Increased levels of G-CSF are observed in patients with HCC. Further investigations are necessary to clarify the mechanism of G-CSF production and its effects on outcomes.
